@ShahidNShah
The Benefits of Diversifying a Hospice’s Referral Mix
In light of evolving dynamics within the healthcare sector, hospices find themselves compelled to diversify their sources of referrals. Factors driving this imperative transformation encompass value-based payment models, workforce shortages, heightened regulatory scrutiny, and reimbursement stagnation via escalating costs, as per a recent report by Transcend Strategy Group. The landscape further shifts with the advent of major payer companies, demographic trends, and a burgeoning emphasis on health equity. Relying solely on a solitary referral source, such as hospitals or skilled nursing facilities (SNFs), is deemed excessively perilous in this era, warns Transcend's President and CEO, Stephanie Johnston. Singular focus on one referral channel can intensify competition among providers. Furthermore, some referral entities may have financial incentives misaligned with early hospice referrals or engagement with a particular provider. In response, hospices should contemplate patients and families as potential referral sources, while ramping up consumer-oriented marketing efforts.
Medigy Insights
The evolving healthcare landscape necessitates diversification of referral sources for hospices. This imperative is driven by factors including value-based payment models, workforce shortages, regulatory scrutiny, and reimbursement challenges, as evidenced in a recent Transcend Strategy Group report. Major payer companies, demographic shifts, and a focus on health equity further reshape this landscape. Relying solely on one referral source, such as hospitals or skilled nursing facilities, is deemed risky. This can intensify competition, and some referral entities may have conflicting financial incentives. Hospices should consider patients and families as potential referral sources and enhance consumer-oriented marketing efforts in response.
Continue reading at hospicenews.com
Make faster decisions with community advice
Next Article
-
Stakeholders Seek Guidance, Clarity from FDA on At-Home Medical Technologies
Stakeholders spanning various industries are urging the US Food and Drug Administration (FDA) to reevaluate its oversight of at-home medical technologies in comparison to those used in conventional …